Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The emerging era of pharmacogenomics: current successes, future potential, and challenges.

Clinical genetics - 1 Jul 2014

Lee J W, Aminkeng F, Bhavsar A P, Shaw K, Carleton B C, Hayden M R, Ross C J D

Abstract excerpt

The vast range of genetic diversity contributes to a wonderful array of human traits and characteristics. Unfortunately, a consequence of this genetic diversity is large variability in drug response between people, meaning that no single medication is safe and effective in everyone. The debilitating and sometimes deadly consequences of adverse drug reactions (ADRs) are a major and unmet problem of modern...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anthracyclines
Share to Biomarkers, Pharmacological
Share to Carbamazepine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cisplatin

Share to Codeine

Share to Pharmacogenetics

Share to Precision Medicine

Share to Warfarin

Source

Open in PubMed Open full text

Identifiers

PMID: 24684508
DOI: 10.1111/cge.12392
PMCID: PMC4233969

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The emerging era of pharmacogenomics: current successes, future potential, and challenges.PMID 24684508Read ↗

Digging up the human genome: current progress in deciphering adverse drug reactions.Semantic proximity Read ↗

The role of pharmacogenomics in adverse drug reactionsSemantic proximity Read ↗

Pharmacogenomics: historical perspective and current status.Semantic proximity Read ↗

Pharmacogenomics: questions and concerns.Semantic proximity Read ↗

Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug ReactionsSemantic proximity Read ↗

Pharmacogenomics: An evolving clinical tool for precision medicine.Semantic proximity Read ↗

Pharmacogenomics: Challenges and OpportunitiesSemantic proximity Read ↗

Genomics of Adverse Drug Reactions.Semantic proximity Read ↗

Advances in pharmacogenetics and pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.Semantic proximity Read ↗

Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG).Semantic proximity Read ↗

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.